Heart failure and pathological overgrowth of the heart often occur hand in hand. New data on a biomechanical sensor challenge the viewpoint that cardiac hypertrophy causes heart failure (pages 68–75).
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Human KATP channelopathies: diseases of metabolic homeostasis
Pflügers Archiv - European Journal of Physiology Open Access 24 December 2009
-
Melusin gene (ITGB1BP2) nucleotide variations study in hypertensive and cardiopathic patients
BMC Medical Genetics Open Access 17 December 2009
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Brancaccio, M. et al. Melusin, a muscle-specific integrin β1-interacting protein, is required to prevent cardiac failure in response to chronic pressure overload. Nature Med. 9, 68–75 (2003).
Molkentin, J.D. & Dorn, I.G., 2nd . Cytoplasmic signaling pathways that regulate cardiac hypertrophy. Annu. Rev. Physiol. 63, 391–426 (2001).
Akhter, S.A. et al. Targeting the receptor-Gq interface to inhibit in vivo pressure overload myocardial hypertrophy. Science 280, 574–577 (1998).
Shai, S.Y. et al. Cardiac myocyte-specific excision of the β1 integrin gene results in myocardial fibrosis and cardiac failure. Circ. Res. 90, 458–464 (2002).
Giancotti, F.G. & Ruoslahti, E. Integrin signaling. Science 285, 1028–1032 (1999).
Brancaccio, M. et al. Melusin is a new muscle-specific interactor for β(1) integrin cytoplasmic domain. J. Biol. Chem. 274, 29282–29288 (1999).
Rockman, H.A. et al. Segregation of atrial-specific and inducible expression of an atrial natriuretic factor transgene in an in vivo murine model of cardiac hypertrophy. Proc. Natl. Acad. Sci. USA 88, 8277–8281 (1991).
Rockman, H.A., Koch, W.J. & Lefkowitz, R.J. Seven-transmembrane-spanning receptors and heart function. Nature 415, 206–212 (2002).
Esposito, G. et al. Genetic alterations that inhibit in vivo pressure-overload hypertrophy prevent cardiac dysfunction despite increased wall stress. Circulation 105, 85–92 (2002).
Adams, J.W. et al. Enhanced Gαq signaling: A common pathway mediates cardiac hypertrophy and apoptotic heart failure. Proc. Natl. Acad. Sci. USA 95, 10140–10145 (1998).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Barki-Harrington, L., Rockman, H. Sensing heart stress. Nat Med 9, 19–20 (2003). https://doi.org/10.1038/nm0103-19
Issue Date:
DOI: https://doi.org/10.1038/nm0103-19
This article is cited by
-
Human KATP channelopathies: diseases of metabolic homeostasis
Pflügers Archiv - European Journal of Physiology (2010)
-
Melusin gene (ITGB1BP2) nucleotide variations study in hypertensive and cardiopathic patients
BMC Medical Genetics (2009)